Please use this identifier to cite or link to this item:
http://hdl.handle.net/11375/17017
Title: | Cost-effectiveness of enoxaparin versus warfarin for prevention of deep vein thrombosis following total hip replacement |
Other Titles: | Enoxaparin versus warfarin for prevention of deep vein thrombosis following total hip replacement |
Authors: | O'Brien, Bernie J. Anderson, David. Goeree, Ron. Centre for Health Economics and Policy Analysis |
Keywords: | Cost-Benefit Analysis;Heparin, Low-Molecular Weight;therapeutic use;Heparin, Low-Molecular Weight;economics;Hip Prosthesis;complications;Thrombophlebitis;prevention & control;Warfarin;therapeutic use;Warfarin;economics;Economics, Medical |
Publication Date: | 1993 |
Publisher: | McMaster University |
Series/Report no.: | CHEPA working paper series no. 93-6 |
Description: | Bernie J. O'Brien, David Anderson, Ron Goeree. -- Bibliography: leaves 19-22. |
URI: | http://hdl.handle.net/11375/17017 |
Appears in Collections: | CHEPA Working Paper Series |
Files in This Item:
There are no files associated with this item.
Items in MacSphere are protected by copyright, with all rights reserved, unless otherwise indicated.